EEG
FOMX

E.E. Geduld’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

E.E. Geduld’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,843
Closed -$156K – 213
2016
Q3 		$156K Buy
+16,843
New +$141K 0.16% 104

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

E.E. Geduld's FOMX Position: Q4 2016 in Review

E.E. Geduld sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2016, closing a stake of 16,843 shares — an estimated $156K sold.

E.E. Geduld first reported a position in FOMX in Q3 2016 and held it in 1 quarter. The position peaked at $156K in Q3 2016. 64 funds tracked by Wall St. Rank hold FOMX as of Q4 2016.

  • E.E. Geduld reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • E.E. Geduld sold 16,843 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2016, an estimated $156K.
  • E.E. Geduld first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2016 and held it in 1 quarter.
  • E.E. Geduld's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $156K in Q3 2016.
  • 64 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.